Literature DB >> 11334114

International consensus statement on idiopathic pulmonary fibrosis.

U Costabel1, T E King.   

Abstract

Entities:  

Mesh:

Year:  2001        PMID: 11334114     DOI: 10.1183/09031936.01.17201630

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  12 in total

Review 1.  Gene expression profiling as a window into idiopathic pulmonary fibrosis pathogenesis: can we identify the right target genes?

Authors:  Naftali Kaminski; Ivan O Rosas
Journal:  Proc Am Thorac Soc       Date:  2006-06

2.  Pneumothorax After Transbronchial Biopsy in Pulmonary Fibrosis: Lessons from the Multicenter COMET Trial.

Authors:  Jonathan A Galli; Nicholas L Panetta; Nathaniel Gaeckle; Fernando J Martinez; Bethany Moore; Thomas Moore; Anthony Courey; Kevin Flaherty; Gerard J Criner
Journal:  Lung       Date:  2017-06-16       Impact factor: 2.584

3.  Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans.

Authors:  Fengrong Zuo; Naftali Kaminski; Elsie Eugui; John Allard; Zohar Yakhini; Amir Ben-Dor; Lance Lollini; David Morris; Yong Kim; Barbara DeLustro; Dean Sheppard; Annie Pardo; Moises Selman; Renu A Heller
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

Review 4.  Therapeutic update in idiopathic pulmonary fibrosis.

Authors:  Andrew L Chan; Rokhsara Rafii; Samuel Louie; Timothy E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2013-02       Impact factor: 8.667

5.  Prolidase could act as a diagnosis and treatment mediator in lung fibrosis.

Authors:  Ibrahim Türkbeyler; Tuncer Demir; Yavuz Pehlivan; Davut Sinan Kaplan; Ali Osman Ceribasi; Mustafa Orkmez; Nurten Aksoy; Seyithan Taysi; Bunyamin Kisacik; Ahmet Mesut Onat
Journal:  Inflammation       Date:  2012-10       Impact factor: 4.092

6.  Respiratory reovirus 1/L induction of intraluminal fibrosis, a model of bronchiolitis obliterans organizing pneumonia, is dependent on T lymphocytes.

Authors:  Elizabeth I Majeski; Manjeet K Paintlia; Andrea D Lopez; Russell A Harley; Steven D London; Lucille London
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

7.  A review of current and novel therapies for idiopathic pulmonary fibrosis.

Authors:  Rokhsara Rafii; Maya M Juarez; Timothy E Albertson; Andrew L Chan
Journal:  J Thorac Dis       Date:  2013-02       Impact factor: 2.895

Review 8.  Serum biomarkers in interstitial lung diseases.

Authors:  Argyris Tzouvelekis; George Kouliatsis; Stavros Anevlavis; Demosthenes Bouros
Journal:  Respir Res       Date:  2005-07-21

Review 9.  Angiogenesis in interstitial lung diseases: a pathogenetic hallmark or a bystander?

Authors:  Argyris Tzouvelekis; Stavros Anevlavis; Demosthenes Bouros
Journal:  Respir Res       Date:  2006-05-25

10.  My approach to interstitial lung disease using clinical, radiological and histopathological patterns.

Authors:  K O Leslie
Journal:  J Clin Pathol       Date:  2009-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.